← brief for 2026-08-10 · Slowing decline

Outcomes of Physiologic Insulin Resensitization (PIR) in Patients With Chronic Kidney Disease and Type 2 Diabetes Mellitus

Trial No results yet Not peer reviewed

Key takeaways

This study looks at 'physiologic insulin resensitization,' a specific way of giving insulin, in people who have both kidney disease and type 2 diabetes. It is just beginning and has no results yet.

Who did this work

Run by Well Cell Global. Sungchun Lee, MD (Arizona Kidney Disease and Hypertension Centers)
Sites: Arizona Kidney Disease and Hypertension Center · Innovative Diabetic Center

Source

Trial registration · ClinicalTrials.gov — CKD recruiting · 2026-08-04
https://clinicaltrials.gov/study/NCT07187479